Evidence map›Paper›PMID 39952360›Full record

ArticleJournal of thrombosis and haemostasis : JTH2025

Galloylated polyphenols represent a new class of antithrombotic agents with broad activity against thiol isomerases.

Moua Yang, Ivan Hancco Zirena, Quinn P Kennedy, Anika Patel, Glenn Merrill-Skoloff, Kelsey D Sack, Emmy Fulcidor, Christina Scartelli, Shihui Guo, Roelof H Bekendam and 6 more

Abstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Molecular mechanisms of protein disulfide isomerase antagonism by punicalagin.Biochemical and biophysical research communications · 2026
    Article
  2. Article
  3. bioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Moua YangBloodworks Northwest Research Institute, Seattle, Washington, USA; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA; Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA. Electronic address: myang@bloodworksnw.org.
Ivan Hancco ZirenaDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA; Department of Anesthesia, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Quinn P KennedyDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Anika PatelDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Glenn Merrill-SkoloffDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Kelsey D SackDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Emmy FulcidorDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Christina ScartelliDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Shihui GuoDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Roelof H BekendamDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Osamede C OwegieBloodworks Northwest Research Institute, Seattle, Washington, USA.
Huanzhang XieCollege of Materials and Chemical Engineering, Minjiang University, Fujian Key Laboratory on Conservation and Sustainable Utilization of Marine Biodiversity, Fuzhou Institute of Oceanography, Fuzhou, China.
Ionita C GhiranDepartment of Anesthesia, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Oren LevyDepartment of Anesthesia, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Lin LinCollege of Materials and Chemical Engineering, Minjiang University, Fujian Key Laboratory on Conservation and Sustainable Utilization of Marine Biodiversity, Fuzhou Institute of Oceanography, Fuzhou, China.
Robert FlaumenhaftDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA. Electronic address: rflaumen@bidmc.harvard.edu.

Funding

PROGRAM IN BLOOD COAGULATION AND VASCULAR BIOLOGYT32HL007917 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Robert C Flaumenhaft · 1999 to 2026
$11.1M
Thiol Isomerases in Hemostasis and ThrombosisR35HL135775 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FLAUMENHAFT, ROBERT C · 2017 to 2023
$5.5M
Biomarkers and mechanisms in cancer associated thrombosisU01HL143365 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CHAIKOF, ELLIOT, FLAUMENHAFT, ROBERT C · 2018 to 2022
$4.3M
Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detectionR01CA218500 · NCI · NORTHEASTERN UNIVERSITY · PI DEL MONTE, FEDERICA, GHIRAN, IONITA CALIN · 2018 to 2022
$4.0M
Thiol Isomerases and Oxidant Stress in Thrombus FormationR01HL167383 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Robert C Flaumenhaft · 2024 to 2026
$2.0M
Integrative, multi-parametric characterization of the EV surface protein and nucleic acid landscape by nano-flow and sorting cytometryUH3TR002881 · NCATS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI GHIRAN, IONITA CALIN, JONES, JENNIFER · 2021 to 2022
$1.9M
Integrative, multi-parametric characterization of the EV surface protein and nucleic acid landscape by nano-flow and sorting cytometryUG3TR002881 · NCATS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI GHIRAN, IONITA CALIN, JONES, JENNIFER · 2019 to 2020
$816k
Oxidative Cysteine Modification by Thiol Isomerases in Sickle Cell DiseaseR00HL164888 · NHLBI · BLOODWORKS · PI Moua Yang · 2024 to 2026
$747k
NCATS NIH HHS UG3 TR002881NCATS NIH HHS UH3 TR002881NCI NIH HHS R01 CA218500NHLBI NIH HHS R00 HL164888NHLBI NIH HHS R01 HL167383NHLBI NIH HHS R35 HL135775NHLBI NIH HHS T32 HL007917NHLBI NIH HHS U01 HL143365
6 · The paper itself

Abstract

backgroundBoth protein disulfide isomerase (PDI) and SARS-CoV-2 main protease (M

objectivesOur goal was to identify phytochemical inhibitors of SARS-CoV-2 M

methodsPDI, ERp57, ERp5, ERp46, isolated domains of PDI, and PDI mutants were used to evaluate the effects of galloylated polyphenols and their analogs on thiol isomerase reductase activity. Laser-injury and ferric chloride models of thrombus formation and a tail snip assay were used to assess the effects on thrombosis and hemostasis.

resultsPinocembrin 7-O-(3''-galloyl-4'',6''-(S)-hexahydroxydiphenoyl)-β-D-glucose (PGHG) inhibited both PDI and SARS-CoV-2 M

conclusionsGalloylated polyphenols represent a large class of antithrombotic compounds with broad activity against thiol isomerases. Many of these compounds also inhibit SARS-CoV-2 M

Indexed as

Coronavirus 3C ProteasesCOVID-19 Drug TreatmentFibrinolytic AgentsPolyphenolsProtein Disulfide-IsomerasesSARS-CoV-2ThrombosisAnimalsCOVID-19HumansMice3C-like proteinase, SARS-CoV-2Coronavirus 3C ProteasesFibrinolytic AgentsPolyphenolsProtein Disulfide-Isomerasesgalloylated polyphenolprotein disulfide isomerasethiol isomerasethrombosis

Identifiers

PMID39952360
PMCPMC12207995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.